Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment

Though antiretroviral therapy is the standard of care for people living with HIV, its treatment limitations, burdens, stigma and costs lead to continued interest in HIV cure research. Early-phase cure trials, particularly those that include analytic treatment interruption (ATI), involve uncertain an...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Med Ethics
Hlavní autoři: Henderson, Gail E, Peay, Holly L, Kroon, Eugene, Cadigan, Rosemary Jean, Meagher, Karen, Jupimai, Thidarat, Gilbertson, Adam, Fisher, Jill, Ormsby, Nuchanart Q, Chomchey, Nitiya, Phanuphak, Nittaya, Ananworanich, Jintanat, Rennie, Stuart
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2018
Témata:
Research Ethics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5869463/
https://ncbi.nlm.nih.gov/pubmed/29127137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/medethics-2017-104433
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky